15 results on '"Horack, Martin"'
Search Results
2. Does Body Mass Index Impact The Choice Of Lipid Lowering Treatment?
3. CONSEQUENT USE OF AVAILABLE ORAL LIPID LOWERING AGENTS WOULD BRING THE MAJORITY OF HIGH-RISK PATIENTS WITH CHD TO RECOMMENDED TARGETS: AN ESTIMATE BASED ON THE DYSIS II STUDY POPULATION
4. Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world
5. Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world
6. DOES CONCOMITANT DIABETES MELLITUS IMPACT THE CHOLESTEROL TREATMENT POST ACS?
7. UNDERTREATMENT OF FEMALE PATIENTS IN LIPID-LOWERING FOR SECONDARY PREVENTION IN EUROPE, CANADA, SOUTH-AFRICA, MIDDLE EAST AND CHINA: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS)
8. IMPROVEMENT OF LDL-CHOLESTEROL GOAL ATTAINMENT IN HIGH-RISK PATIENTS IN EUROPE AND MIDDLE EAST BETWEEN 2008-09 AND 2013-14: RESULTS OF DYSIS AND DYSIS II CHD
9. LOW LDL-CHOLESTEROL TARGET VALUE ATTAINMENT AT THE TIME OF ACUTE CORONARY SYNDROME (ACS) AND EVEN 4 MONTHS AFTER THE ACUTE EVENT DUE TO LACK OF ADJUSTMENT IN LIPID LOWERING TREATMENT: RESULTS FROM THE DYSLIPIDEMIA INTERNATIONAL STUDY II ACS
10. FREQUENCY AND PREDICTORS OF CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE: RESULTS FROM THE DYSLIPIDEMIA INTERNATIONAL STUDY II
11. Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world
12. Does Body Mass Index Correlate To Lipoproteins And Triglycerides? Findings From DYSIS In 52.916 Statin Treated Patients
13. STILL HIGH PREVALENCE OF PERSISTENT LIPID ABNORMALITIES AMONG CORONARY PATIENTS DESPITE CHRONIC STATIN THERAPY IN 2014: RESULTS OF DYSIS II ACS AND CHD
14. ESTIMATED PREVALENCE OF POSSIBLE AND PROBABLE FAMILIAL HYPERCHOLESTEROLEMIA IN 35,451 STATIN-TREATED PATIENTS IN EUROPE, CANADA, THE MIDDLE EAST, AND SOUTH AFRICA
15. PERSISTENT HIGH DISTANCE TO RECOMMENDED LDL-CHOLESTEROL-TARGETS DESPITE CHRONIC STATIN TREATMENT: RESULTS OF DYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.